Prolongation of Prothrombin times in patient samples, resulting in a falsely elevated INR value.
Source facts
Action
Letters dated 11/1/2004 with instructions to (1) Discard remaining kits; (2) notify end-users; (3) Evaluate patient records when the kits were used to monitor Oral Anti-coagulant Therapy.
Initiated
2004-10-27
Root cause
Other
Terminated
2005-07-25
Distribution
Trinity Biotech, Jamestown, NY sold product to 87 customers: 10 distributors (7 in U.S. & 3 foreign); 1 exporter; and 76 end users. 84 of those customers are located in the United States. There is one consignee in Canada, one in Brazil, and one in Venezuela. In addition, the manufacturer in Ireland sold additional units of this lot to other countries.
Recall number
Z-0261-05
Recall status
Terminated
CDRH record ID
35722
FDA classified
2004-11-30
Recall event number
30354
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.